Methylene blue is not a peptide, but it lives on every peptide-clinic menu and in every longevity stack, so it belongs in this library, covered with the same rules. It is genuinely interesting: a synthetic dye from 1876 that became an FDA-approved drug (for methemoglobinemia) and a mitochondrial research darling. It also carries one of the most clinically real drug interactions in the entire wellness space, which most sellers never mention.
What it is and why longevity people take it
Methylene blue is a redox-cycling compound: at low doses it can accept and donate electrons within mitochondria, acting as an alternative electron carrier and mild antioxidant. That mechanism, plus animal and small human studies on cognition and cellular energetics, powers the biohacker use. The approved medical use is different and unambiguous: it treats methemoglobinemia, and a pharmaceutical form (ProvayBlue) exists for it.
The hormetic dose curve, and what people actually take
Methylene blue's signature property is a biphasic dose response: low doses support electron transport; high doses flip it into a pro-oxidant that impairs the same machinery. The medical dose for methemoglobinemia runs 1 to 2 mg/kg intravenously; longevity protocols cluster far lower, typically fixed oral doses in the 5 to 50 mg range. More is not better here in the most literal, mechanistic sense, and stacking sources (capsules plus troches plus IV pushes at a clinic) is how people drift up the curve without noticing.
The interaction that actually hospitalizes people
- Methylene blue is a potent MAO-A inhibitor. Combined with serotonergic drugs (SSRIs, SNRIs, tramadol, MDMA), it can trigger serotonin syndrome; the FDA has warned about exactly this, and cases are documented at medical doses.
- Anyone on an antidepressant should treat methylene blue as contraindicated until a prescriber who knows both facts says otherwise. This single line is missing from most wellness pages selling it.
- G6PD deficiency is the other hard contraindication: methylene blue can cause hemolysis in that population.
- Cosmetic note that prevents panic: it turns urine blue-green. Harmless, startling, and diagnostic of the fact you took a dye.
The grade problem
Methylene blue is sold as aquarium disinfectant, industrial stain, chemical-lab reagent, and pharmaceutical (USP) grade, and the non-pharmaceutical grades legally carry heavy-metal and contaminant levels no one should swallow. If a product does not state USP or pharmaceutical grade with a lot-specific certificate, it is fish-tank chemistry at supplement prices. This is the one wellness compound where the sourcing warning is not boilerplate.
Frequently asked questions
What does methylene blue do?
Medically, it treats methemoglobinemia by restoring hemoglobin's oxygen-carrying state. In longevity use, low doses act as a mitochondrial electron shuttle with antioxidant behavior; human outcome evidence for cognition and aging is early and modest, well behind the enthusiasm.
Is methylene blue safe to take?
At low oral doses, for people on no serotonergic medication and without G6PD deficiency, reported tolerability is good. The two hard stops: SSRIs/SNRIs and related drugs (serotonin-syndrome risk via MAO inhibition, FDA-warned) and G6PD deficiency (hemolysis).
What dose of methylene blue do people take?
Longevity protocols typically use fixed oral doses around 5 to 50 mg, far below the 1 to 2 mg/kg IV medical dosing. The dose-response is biphasic, so 'more' actively defeats the mechanism people take it for.
Why is pharmaceutical grade so important for methylene blue?
Because most methylene blue on the market is industrial or aquarium grade, with permitted contaminant levels (including heavy metals) that were never meant for ingestion. USP grade with a certificate of analysis is the floor, not a bonus.